Paper 23 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED METASTATIC OSTEOSARCOMA: FINAL RESULTS

Author(s)

• 

  J. Andrew Livingston, MD, MS

  Associate Professor
  The University of Texas MD Anderson Cancer Center, Houston, TX, USA
  Houston, Texas, United States

  Slides

Co-Author(s)

• JG

  Jonathan B. Gill, MD

  Professor
  University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• 

  Anthony P. Conley, MD

  Associate Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• 

  Neeta Somaiah, MD

  Professor & Deputy ChairSarcoma Medical Oncology
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• 

  Dejka Araujo, MD

  Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• 

  Ravin Ratan, MD, MEd

  Associate Professor
  University of Texas, MD Anderson Cancer Center, Department of Sarcoma Medical Oncology, Division of Cancer Medicine
  Houston, Texas, United States
• VR

  Vinod Ravi, MD, MBA

  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• AZ

  Alex Zarzour, MD

  Associate Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• RB

  Robert Benjamin, MD

  Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• SP

  Shreyaskumar Patel, MD MS

  Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• ND

  Najat Daw, MD

  Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• DH

  Douglas J. Harrison, MD

  Professor of Pediatrics
  University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• RG

  Richard Gorlick, MD

  Professor, Division Head
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• TO

  Taryn Otto, BA

  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• HL

  Heather Lin, PhD

  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• WW

  Wei-lien Wang, MD

  Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• 

  Behrang Amini, MD PhD

  Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• EK

  Eugenie Kleinerman, MD

  Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• NG

  Nancy Gordon, MD

  Associate Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States